Medical Technology and Digital Health companies are clear beneficiaries, particularly those working on:

• Class II or Class III medical devices (these are FDA risk classifications where Class
  II includes moderate-risk devices like surgical robots, and Class III includes
  high-risk devices like implantable pacemakers)
• SaMD (Software as Medical Device), which refers to software intended for medical
  purposes, including those utilizing AI/ML, that performs these purposes without
  being part of a hardware medical device
• CGMs (Continuous Glucose Monitors), which are devices that track blood glucose levels throughout the day and night Pharmaceutical manufacturers spend billions on quality and validation work across their manufacturing facilities and are eager to utilize AI to improve their operations

Outside of life sciences, the same “safety-critical playbook” exists across other industries like automotive, aerospace, and energy. Because Ketryx AI Agents ingest a customer’s governing processes, understand live engineering and product lifecycle data, and generate audit-ready evidence automatically, these industries stand to gain the same 90% documentation reduction and 10× faster release cycles our MedTech users already see. We expect MedTech to serve as the proving ground for validated AI operations across all safety-critical sectors.